SEMGLEE

Subcutaneous biosimilar medications for patient self-administration

COMMERCIAL BRAND
SEMGLEE

ACTIVE PRINCIPLE
INSULIN GLARGINE

TYPE OF DEVICE
PRE-FILLED PEN

LATEX
DO NOT

TEMPERING TIME
Until reaching 15-30ºC

START OF INJECTION
Inserting the needle into the skin

CLICK TO THE START (IN PEN)
DO NOT

CLICK AT THE END (IN PEN)
DO NOT

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE